5AB-33925-91898
4 vaccinations
4 coded responses
33 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 490 / MI
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: PainFree text: Lymph nodes swollen (especially arm pit on side of injection)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-12-01
Dose 3 — Moderna
-
2022-02-02
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-06-01
-
2022-09-12
Dose 4 — ModernaCo-administered: Flu
-
2022-09-19
Survey response — day 7, dose 4MedDRA: Oropharyngeal pain — Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-09-28
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-12-12
-
2023-03-13
Survey response — 6 months, dose 4MedDRA: Norovirus infection, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Moderna | No |
| 4 | 2022-09-12 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-02 | Successful 2022-03-16 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph nodes swollen (especially arm pit on side of injection)
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Release 12 — day 7, dose 4
Systemic reaction (other): Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Norovirus infection | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release